Blue Horseshoe Stocks: HZNP Options Update & More

Horizon Pharma plc  HZNP

Our first idea of the week in yesterday’s premarket report, which was to track the HZNP Weekly $14 and 15 Calls, ended up paying instant dividends. HZNP was coming off of its earnings call as well as highlighting a new 5M share repurchase program.

Both of our targeted sets of contracts experienced significant intraday swing action which traders could have utilized for solid single-session gains. The $14 Calls ran impressively from a low of .88 to a subsequent high of 2.15, for a 144% rip. The $15′s put up a pleasing performance of similar magnitude, trading in a range from .60-1.33, for total possible profits of up to 122%

We identified 16.15 as an indicating point, the breaching of which would signal us to roll up our strike price to $16. That still remains true as we continue along through the week.


Aperture Health, Inc. APRE – Update

We want to provide an update this morning on the recent progress of APRE, which our regular readers will recollect was a point of focus for us beginning a couple of weeks ago. We’ve tracked it over several swings, commenting on the stock’s ability to make volatile moves to the upside. It continues to demonstrate this ability over recent sessions, wherein we’ve observed quite a rush of momentum.

From last Wednesday’s bounce-point of .0188, we’ve now seen a swing of 165% as of yesterday’s new high of .0499 and the stock recorded its highest volume since November. Presently, indicators on the chart seem to be ripe and ready for the possibility of even higher highs. The next key areas of resistance following a nickel are sitting at .08 and .115.


You may also view the highlights of the chart on the following video presentation:


Extended Watchlist:
CCTL, ISLT, ALXA, NOK, CCXI